Guardian Pharmacy Services, Inc. $GRDN Stock Sold by Sterling Capital Management LLC

Sterling Capital Management LLC reduced its stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 94.8% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,054 shares of the company’s stock after selling 19,267 shares during the quarter. Sterling Capital Management LLC’s holdings in Guardian Pharmacy Services were worth $43,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Jennison Associates LLC grew its position in shares of Guardian Pharmacy Services by 609.5% in the first quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock valued at $30,986,000 after purchasing an additional 706,823 shares in the last quarter. Sei Investments Co. increased its holdings in shares of Guardian Pharmacy Services by 40.5% in the first quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock valued at $13,489,000 after purchasing an additional 103,177 shares during the last quarter. Braun Stacey Associates Inc. acquired a new stake in shares of Guardian Pharmacy Services in the second quarter valued at approximately $14,234,000. Dimensional Fund Advisors LP lifted its position in Guardian Pharmacy Services by 200.0% during the first quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock worth $7,855,000 after buying an additional 139,070 shares in the last quarter. Finally, Ranger Investment Management L.P. purchased a new position in Guardian Pharmacy Services during the second quarter worth approximately $7,263,000.

Guardian Pharmacy Services Price Performance

Guardian Pharmacy Services stock opened at $42.03 on Thursday. The firm has a 50 day simple moving average of $41.28 and a 200-day simple moving average of $38.17. Guardian Pharmacy Services, Inc. has a 1-year low of $26.34 and a 1-year high of $48.33. The stock has a market cap of $2.09 billion, a price-to-earnings ratio of 40.81, a price-to-earnings-growth ratio of 2.13 and a beta of 0.06.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. The firm had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. Equities analysts expect that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

GRDN has been the topic of a number of recent research reports. Oppenheimer boosted their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a research note on Friday, August 7th. KeyCorp began coverage on Guardian Pharmacy Services in a research note on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 target price for the company. Weiss Ratings downgraded Guardian Pharmacy Services from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, October 23rd. Wall Street Zen lowered Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a report on Sunday, October 25th. Finally, Truist Financial boosted their price target on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a research report on Monday, September 21st. Nine equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Guardian Pharmacy Services has an average rating of “Moderate Buy” and a consensus price target of $45.57.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents’ medication regimens.